501
Participants
Start Date
December 4, 2019
Primary Completion Date
August 22, 2022
Study Completion Date
August 22, 2022
Columbia University, New York
James J. Peters VAMC, The Bronx
University of Mississippi Medical Center, Jackson
Cleveland Clinic, Cleveland
Centro de Estudios de Investigacion Basica y Clinica, SC, Guadalajara
Dallas VA Medical Center VANTHCS, Dallas
University of Texas Health Science Center at Houston, Houston
University of Colorado, Aurora
VA Long Beach Healthcare System, Long Beach
UCSF Medical Center - Rheumatology Clinic, San Francisco
Sacramento VA Medical Center, Mather
Oregon Health & Science University, Portland
Seattle Rheumatology Associates, Seattle
Yale University School of Medicine, New Haven
Brigham & Women's Hospital, Boston
Boston University School of Medicine, Boston
Artus Health Center, Vancouver
The Ottawa Hospital, Ottawa
University Health Network, Toronto
CLIDITER, Mexico City
Collaborators (5)
AbbVie
INDUSTRY
Amgen
INDUSTRY
Janssen Scientific Affairs, LLC
INDUSTRY
Eli Lilly and Company
INDUSTRY
Novartis Pharmaceuticals
INDUSTRY
Pfizer
INDUSTRY
UCB Pharma
INDUSTRY
Spondyloarthritis Research and Treatment Network
NETWORK